ArticleBreast cancer research and treatment2019

Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES.

Zsolt Szijgyarto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.